Phobic Disorders Clinical Trial
— PACTE-qOfficial title:
Screening for Phobia of Falling in the Elderly: Validity and Feasibility of a Self-administered Questionnaire
Verified date | October 2015 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Observational |
The aim of this study is to determine the validity of a self-questionnaire detecting seniors phobia of falling living at home. A prospective monocentric observational study compares in a blind way the presence of Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria for specific phobia, considered as the gold standard to the score obtained at the detecting questionnaire for ≥70 years old seniors suspected of phobia of falling and attending geriatric day hospital at the Bretonneau hospital (APHP, Paris).
Status | Completed |
Enrollment | 41 |
Est. completion date | October 2015 |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 70 Years and older |
Eligibility |
Inclusion Criteria: - Aged 70 years and over - Presenting walking difficulties and/or disturbance of the balance and/or at least one fall during the course of the last 5 years and/or a fear of falling - Living in community - Non opposition of the patient to the collection of his personal data Exclusion Criteria: - Depression - Cognitive disorders - Inability to communicate |
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
France | Hôpital Bretonneau | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concordance of the self-questionnaire score compared to the gold standard formed by DSM-IV criteria for specific phobia presence | In a first time, the optimal threshold of the self-questionnaire score will be determined with a ROC curve. In a second time, this threshold will let us evaluate the score concordance compared to reference method. | 1 day | No |
Secondary | Percentage of filled out self-questionnaires | Evaluation of construct validity of the self-questionnaire | 1 day | No |
Secondary | Item response rate | Evaluation of construct validity of the self-questionnaire | 1 day | No |
Secondary | Help requirement to fill out the self-questionnaire | Evaluation of construct validity of the self-questionnaire | 1 day | No |
Secondary | Time to complete the self-questionnaire | Evaluation of construct validity of the self-questionnaire | 1 day | No |
Secondary | Patients' satisfaction with the self-questionnaire | Evaluation of construct validity of the self-questionnaire | 1 day | No |
Secondary | Life-space mobility assessed by the Life-Space Assessment | 1 day | No | |
Secondary | Comorbidity assessed by the Cumulative Illness Rating Scale for Geriatrics | 1 day | No | |
Secondary | History of falls, number and gravity | 1 day | No | |
Secondary | Frailty assessment according to phenotype definition of Fried | Evaluation of construct validity of the self-questionnaire | 1 day | No |
Secondary | The Fear Questionnaire | 1 day | Yes | |
Secondary | The Mobility Inventory for Agoraphobia | 1 day | No | |
Secondary | Fear of falling assessed by the Falls Efficacy Scale-International | 1 day | No | |
Secondary | Self-rated health assessed by the Minimum European Health Module | 1 day | No | |
Secondary | The Timed Up and Go, performance-Oriented Mobility Assessment, 10-m walk test, the 30-s chair-stand test | 1 day | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01963806 -
ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder
|
N/A | |
Completed |
NCT00121069 -
Study of Escitalopram in the Treatment of Specific Phobia
|
Phase 2/Phase 3 | |
Recruiting |
NCT03653923 -
Neurophysiological Correlates of Exposition Therapy in Spider Phobia
|
N/A | |
Completed |
NCT00184106 -
RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
|
Phase 4 | |
Completed |
NCT00051220 -
Treatment for Specific Phobias in Children
|
Phase 1/Phase 2 | |
Completed |
NCT02310152 -
Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
|
N/A | |
Completed |
NCT00000370 -
Treatment of Social Phobia
|
N/A | |
Completed |
NCT03012035 -
The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants
|
N/A | |
Completed |
NCT02007694 -
Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03188575 -
Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT
|
N/A | |
Completed |
NCT02432703 -
A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
|
Phase 2 | |
Terminated |
NCT01574014 -
Glucocorticoid Treatment for Social Phobia
|
Phase 2 | |
Completed |
NCT00734422 -
Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT02336802 -
Threat-Avoidance Learning in Anxiety Patients
|
N/A | |
Completed |
NCT01361074 -
In Vivo Versus Augmented Reality Exposure for Small Animal Phobia
|
N/A | |
Completed |
NCT00104195 -
A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions
|
Phase 1 | |
Completed |
NCT00035412 -
St. John's Wort Versus Placebo in Social Phobia
|
Phase 2 | |
Completed |
NCT00128401 -
Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
|
Phase 2 | |
Recruiting |
NCT02020824 -
Virtual Reality and Concept of Control in the Treatment of Acrophobia
|
N/A | |
Terminated |
NCT01623583 -
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
|
Phase 4 |